Avadel pharmaceuticals to provide a corporate update and report fourth quarter and full year 2022 financial results on march 30

Dublin, ireland, march 29, 2023 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. et on thursday, march 30, 2023, to provide a corporate update and discuss the company's financial results for the fourth quarter and full year ended december 31, 2022.
AVDL Ratings Summary
AVDL Quant Ranking